Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Prices and filings as of the close on Nov 3, 2026
| # | Company | Share price | 1D | Market cap | Debt/equity | Net debt/EBITDA | Int. coverage | Current ratio | Altman Z | F-score |
|---|---|---|---|---|---|---|---|---|---|---|
| 3501 | $53.23 | −0.84% | $8.3B | – | – | – | – | 0.43 | 6 | |
| 3502 | $27.14 | +10.5% | $8.3B | 1.03 | 1.94 | 3.2× | 1.54 | 4.29 | 6 | |
| 3503 | $36.35 | −1.8% | $8.3B | 0.79 | 5.50 |
| 0.7× |
| 0.78 |
| 0.59 |
| 4 |
| 3504 | $25.23 | +0.40% | $8.3B | 0.84 | 2.72 | 3.6× | 2.13 | 2.49 | 8 |
| 3505 | $76.77 | −2.4% | $8.4B | 0.55 | – | – | – | 0.15 | 4 |
| 3506 | $145.12 | −1.3% | $8.4B | 0.95 | 5.08 | 2.4× | 1.18 | 1.30 | 5 |
| 3507 | $59.53 | −0.07% | $8.4B | – | – | −2.4× | 5.90 | 2.54 | 5 |
| 3508 | fcfsFirstCash | $194.51 | +0.41% | $8.4B | 0.00 | – | – | 4.81 | 3.15 | 8 |
|---|
| 3509 | $102.03 | −1.6% | $8.4B | 0.47 | 1.33 | 6.7× | 2.99 | 4.90 | 9 |
| 3510 | $437.88 | +2.6% | $8.5B | 0.43 | 0.90 | 16.0× | 2.41 | 6.38 | 7 |
| 3511 | $53.62 | −0.74% | $8.5B | 0.75 | 2.57 | 4.3× | 1.56 | 2.43 | 8 |
| 3512 | $12.82 | −2.0% | $8.5B | – | 6.64 | 0.6× | 0.53 | 0.66 | 5 |
| 3513 | $65.29 | +5.9% | $8.5B | 0.00 | – | – | 5.69 | 23.82 | 6 |
| 3514 | $66.25 | +0.87% | $8.5B | 1.24 | 2.39 | 3.1× | 1.06 | 1.83 | 7 |
| 3515 | $38.28 | −0.80% | $8.5B | – | – | – | – | 1.66 | 4 |
| 3516 | $35.07 | +2.7% | $8.5B | 0.72 | 3.21 | – | 2.78 | 2.57 | 7 |
| 3517 | $44.87 | −0.62% | $8.5B | 1.21 | 2.30 | 6.3× | 2.47 | 3.10 | 7 |
| 3518 | $4.27 | +0.95% | $8.6B | 0.00 | – | – | 9.68 | 19.14 | 3 |
| 3519 | $135.62 | +0.53% | $8.6B | – | – | 2.1× | – | 1.77 | 6 |
| 3520 | adcAgree Realty | $68.86 | +0.55% | $8.6B | – | – | 2.6× | – | 1.48 | 5 |
|---|
| 3521 | $32.57 | +5.2% | $8.6B | 0.00 | – | – | 15.49 | 23.63 | – |
| 3522 | $81.63 | +6.6% | $8.6B | 0.80 | 1.81 | 9.2× | 1.67 | 2.97 | 7 |
| 3523 | $247.31 | −0.44% | $8.6B | 0.01 | −0.44 | 22.8× | – | 1.33 | 6 |
| 3524 | $280.23 | −1.2% | $8.6B | – | – | – | – | 0.89 | – |
| 3525 | $29.60 | +4.0% | $8.6B | 0.00 | – | – | – | 5.16 | – |
| 3526 | $207.41 | −2.1% | $8.7B | 1.21 | 0.70 | 12.0× | 0.34 | 5.31 | 8 |
| 3527 | $36.71 | +1.6% | $8.7B | – | – | – | – | 3.77 | 5 |
| 3528 | $63.84 | −2.4% | $8.7B | 0.37 | 0.58 | 26.3× | 1.64 | 6.26 | 7 |
| 3529 | $36.67 | −2.1% | $8.7B | – | – | 5.2× | 0.62 | 1.27 | 6 |
| 3530 | $30.84 | −1.3% | $8.7B | – | – | – | – | 0.13 | 5 |
| 3531 | $52.37 | +0.50% | $8.7B | 0.00 | – | – | 2.41 | 7.65 | 5 |
| 3532 | $383.55 | +1.0% | $8.7B | – | – | – | – | 1.92 | 5 |
| 3533 | $119.36 | −2.7% | $8.7B | 0.79 | 1.21 | 9.9× | 1.02 | 2.97 | 8 |
| 3534 | $68.47 | −3.8% | $8.8B | 0.58 | – | −6.1× | 2.45 | 1.71 | 3 |
| 3535 | syreSpyre Therapeutics | $99.27 | +3.9% | $8.8B | 0.00 | – | – | 18.53 | 72.18 | 4 |
|---|
| 3536 | $56.50 | +1.5% | $8.8B | – | 8.22 | −0.5× | 1.85 | 2.20 | 4 |
| 3537 | $8.29 | +4.3% | $8.8B | – | – | – | 5.72 | −7.44 | 5 |
| 3538 | $73.11 | −1.1% | $8.8B | – | – | – | – | 0.31 | 7 |
| 3539 | $140.30 | +8.7% | $8.8B | 0.00 | – | – | 2.67 | 20.60 | 5 |
| 3540 | $22.87 | −0.69% | $8.8B | – | 0.27 | 14.4× | 1.63 | 3.11 | – |
| 3541 | $54.24 | +1.3% | $8.8B | – | 6.53 | 0.9× | 0.68 | 1.23 | 5 |
| 3542 | $142.72 | −1.9% | $8.8B | 0.24 | 0.56 | – | 1.72 | 3.18 | – |
| 3543 | $164.49 | +3.3% | $8.8B | – | 0.47 | 5.6× | 1.78 | 2.67 | 8 |
| 3544 | $36.85 | 0.00% | $8.8B | – | – | – | – | 0.62 | 5 |
| 3545 | $38.50 | −8.5% | $8.8B | – | −0.70 | 6.1× | 1.79 | 1.19 | – |
| 3546 | $81.93 | +1.8% | $8.9B | 0.00 | – | – | 2.86 | 31.43 | 4 |
| 3547 | $22.05 | −0.99% | $8.9B | 1.60 | −0.04 | 28.5× | 0.84 | 4.80 | 8 |
| 3548 | $13.21 | −2.4% | $8.9B | 0.00 | −0.52 | – | 5.20 | 11.96 | 8 |
| 3549 | $236.71 | −0.85% | $8.9B | – | 1.38 | – | 1.05 | 3.92 | – |
| 3550 | $21.84 | −0.73% | $8.9B | 0.00 | – | – | 2.01 | 0.60 | 6 |